Download free PDF

Bionematicides Market Size & Share 2026-2035

Report ID: GMI783
   |
Published Date: November 2026
 | 
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:

Bionematicides Market Size

The bionematicides market was valued at USD 680 million in 2025 and is projected to reach USD 748 million in 2026, advancing at a CAGR of 9.97% (2026–2035) to USD 1.76 billion by 2035. The market covers microbial and biochemical products registered to control plant-parasitic nematodes, sold to growers for soil, seed, foliar and drip application on food, feed, fibre and commercial crops, with value measured at the level farmers pay.

Bionematicides Market Key Takeaways

2025 Market Size
$ 680 Million
2026 Market Size
$ 748 Million
2035 Forecast Market Size
$ 1.76 Billion
CAGR (2026–2035)
9.97%
Regional Dominance
Largest Market
Latin America
Fastest Growing Region
Asia Pacific
Key Players
  • Market Leader: Sumitomo Biorational Company LLC (formerly Valent BioSciences LLC) led with over 13% market share in 2025.

  • Leading Players: Top 5 players in this market include Sumitomo Biorational Company LLC (formerly Valent BioSciences LLC), Koppert Biological Systems, BASF SE, Certis Biologicals, Bayer AG, which collectively held a market share of 46% in 2025.

Growth is being pulled by a shrinking toolbox. Fumigants and older chemical nematicides face tighter buffer zones, emissions limits and non-renewals, while the root pests they controlled keep spreading through intensified soybean, cotton, vegetable and orchard systems. Growers who once relied on a single preplant chemistry now assemble programs, and biological products have become the layer that regulators and retail buyers can accept. The second force is supply: fermentation plants, seed-treatment lines and simpler registration routes are making Bacillus, Purpureocillium and Trichoderma products easier to formulate, ship and label, which widens the farms that can afford to try them.

GMI Analyst View

Our discussions with industry experts indicate that the market moved 75.56 kilotons of formulated product in 2025, and the volume base matters as much as the revenue line. Nematicide purchases are repeat, seasonal and tied to hectares in infested fields, so tonnage shows how many acres are actually being protected. A market built on retained acreage and renewed seasonal orders is steadier than one built on trial packs, and that distinction shapes how confidently demand can be carried forward through the forecast.

Bionematicides Market Trends, Growth Drivers & GMI Forecast Outlook

Biological nematode control is gaining ground where chemical fumigation is being restricted and where Brazilian growers have already shifted acreage toward biologicals. Efficacy variability, registration cost and competing seed-trait technology will decide how much of that opportunity converts into repeat sales and how fast the product mix shifts toward multi-strain, seed-applied formats.

Key Drivers

DriverEvidence signalMarket-demand implicationGMI forecast condition
Brazilian soybean and cotton adoption of biological nematode controlArea treated with bionematicides in Brazil grew about 60% between 2024 and 2025 [1]Large-acreage growers are moving nematode control from chemical-only programs into biological in-furrow and seed programs, widening the buyer base for Bacillus-based linesSupports Latin American demand from 2026 to 2030, led by soybean and cotton; a slowdown in Brazilian soybean area expansion or a price war among local Bacillus suppliers would lower the outlook
California limits on 1,3-dichloropropene fumigationCalifornia 1,3-dichloropropene emissions fell 29% after the 2024 fumigation rules took effect [2]Nut, fruit and vegetable growers face costlier, slower and less predictable preplant fumigation, which pushes them to add or substitute biological nematicides in replant and high-value blocksSupports North American specialty-crop demand through 2030; if regulators relax the further occupational-bystander limits advanced in 2025, the effect on orchard and vegetable programs would soften
Simplified registration route for similar bioinputs in BrazilBrazil's bioinputs framework, Law 15.070 of December 2024, permits a simplified registration procedure where a similar product is already registered in the country [3]Follow-on Bacillus, Trichoderma and Purpureocillium nematicides can reach labeled use faster and at lower dossier cost, adding suppliers and brands in the largest Latin American marketSupports faster product proliferation in Brazil from 2027 to 2030; slow publication of the implementing rules would delay launches and defer the effect

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Brazil is where the shift from pilot to routine use is most visible. Soybean and cotton growers there face root-lesion, root-knot and cyst pressure that spreads with successive cropping, and an in-furrow or seed-applied biological now sits beside the chemical program rather than outside it. The buyers changing behavior are large farm operators and cooperatives who place orders season by season, so a product that performs once tends to be repeated across more fields. That is why Latin America's weight in the forecast depends on retained hectares, not trial volumes, and why a softer soybean cycle would show up first in order timing.

California shows what restricted fumigation does to purchasing logic. Preplant fumigation of orchard ground and vegetable beds used to be a single decision made by a custom applicator; larger buffer zones, deeper injection, tarps and smaller treatable plots have made it dearer and harder to schedule. Growers of almonds, walnuts, strawberries and tomatoes therefore look at layering a biological nematicide into drip lines or at planting, even when the chemical remains in the plan. The demand consequence falls on North American specialty-crop volumes and on drip and soil formats, and it holds as long as the restrictions stay in place and chemical costs keep rising.

Brazil's registration reform affects who can sell, not only who buys. By letting a company file through a simplified procedure when a similar bioinput is already registered, the law lowers the cost of copying a proven strain and putting it on a label. Established Bacillus suppliers will see more local competition, while regional fermenters, which already make on-farm and commercial biologicals, gain a legal route to commercial scale. More brands usually mean lower prices per hectare and broader distribution, which supports volume more than value. The forecast therefore leans on how quickly the implementing rules arrive and how consistently the registry applies them.

Key Restraints

RestraintEvidence signalMarket-demand implicationGMI forecast condition
Registration cost for new active ingredients in the United StatesEPA's fiscal 2027 registration fee for a new biopesticide active ingredient with no change to a tolerance is USD 30,257 [4]Small strain developers and regional fermenters must fund fees, data packages and review time before first sales, which narrows the number of new microbial and biochemical actives reaching U.S. growersHolds back new-active launches in the United States for the whole forecast period; broader use of fee waivers or faster conditional rulings would ease the constraint
Variable field efficacy of microbial nematicidesIn Corteva's own Brazilian trials in the 2024/25 and 2025/26 seasons, its Amaná microbial nematicide delivered average control efficacy of 62.3% against juvenile and adult nematodes [5]Growers see biologicals as one part of a program rather than a full replacement for chemistry, which caps substitution in heavily infested soybean and cotton fieldsLimits displacement of chemical nematicides in high-pressure fields through 2030; field-proven multi-strain products with consistent trial results would lift the outlook
Seed-trait competition in soybeanBASF has branded Nemasphere, a soybean seed biotechnology against root-lesion and cyst nematodes, with commercial seed planned in Brazil from 2028, subject to regulatory approvals [6]A trait built into the seed moves nematode control into the planting decision and competes with in-furrow and seed-applied biologicals for the same soybean hectaresWeighs on Brazilian soybean in-furrow volumes from 2028 to 2030; a delay in approvals would push the effect later in the decade

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Registration economics decide which products exist before they decide how well any product sells. A new microbial or biochemical active entering the United States has to carry a fee, a data package and a long review before it earns revenue, and the burden falls hardest on small developers whose strain may be effective but whose balance sheet is thin. Large crop-protection companies absorb the cost across portfolios; start-ups usually license or sell. The consequence is a market where new actives arrive slowly and incumbents hold a longer product life, which moderates innovation-led growth in the United States and favors distribution partnerships over independent launches.

Efficacy is the commercial ceiling for microbial products. A manufacturer-run field program that averages well below full control tells an agronomist what to expect: reduction, not elimination. In heavily infested soybean, cotton and vegetable fields, advisers therefore keep a chemical or a resistant variety in the plan and use the biological to lower pressure or protect early root growth. That limits how much chemical revenue the biological category can take in the worst fields while still leaving room in moderate-pressure acres. Multi-strain consortia, better carriers and consistent results across seasons are what raise the ceiling, and results from independent trials will matter more than label claims.

The seed-trait route threatens a specific slice of demand. A soybean trait that works from inside the plant is attractive to growers who want fewer products to apply at planting, and it targets the same root-lesion and cyst nematodes that in-furrow biologicals address in Brazil. Because launch is planned for seed after approvals, the effect arrives late in the forecast and depends on seed-company licensing and variety coverage. Suppliers can respond by emphasizing crops outside the trait's reach, such as cotton, vegetables and sugarcane, and by selling products that stack with the trait rather than compete with it.

GMI Analyst View

The forecast is a contest between two forces that rarely move together: regulatory pressure on fumigants, which creates demand quickly, and field results, which decide whether that demand is repeated. Markets with pressure on chemistry and high-value crops will pull biologicals in first, while large-acreage markets will depend on proof that a product holds up across seasons. Demand will skew toward multi-strain, program-based products, and risk concentrates in efficacy disappointments and slow registrations. Any shift in either force would change timing more than direction.

Bionematicides Market Segment Analysis

By Type

Microbial

Bionematicides Market Size By Type 2025 And 2035 Usd Million
Bionematicides Market Size By Type 2025 And 2035 Usd Million

Microbial products dominate because bacteria and fungi can be fermented at scale, stacked into consortia and registered as low-risk biological actives. Microbial bionematicides generated USD 442 million in 2025 and are expected to reach a 67% share by 2035. Buyers include soybean and cotton growers who apply Bacillus strains in furrow or on seed, and vegetable producers who use fungal parasites of eggs and juveniles. The category's advantage is manufacturing leverage: one fermentation platform can serve many crops and labels.

Bacterial-based

Bacterial-based products accounted for a 50% share in 2025 and are expected to grow at a CAGR of 10.41% (2026–2035). Spore-forming Bacillus strains, including firmus and subtilis types, suit seed coats and in-furrow sprays because spores survive storage and colonize roots. That is a practical edge over fungal products that need cooler storage and longer establishment. Large seed-treatment channels, where a biological is applied in a plant before sale, give bacterial suppliers their route to scale.

Fungal-based

Fungal-based products were valued at USD 102 million in 2025 and are projected to reach USD 264 million by 2035. Paecilomyces and Trichoderma strains, and nematode-trapping fungi such as Arthrobotrys, act on eggs, juveniles or the root zone and suit protected vegetables, fruit and ornamentals where soil moisture is managed. Their buyers pay for targeted action in higher-value crops, but wettable powders and granules need good soil contact, so adoption follows irrigation infrastructure and trained advisers more than acreage.

Biochemical

Biochemical products are expected to reach USD 457.6 million by 2035 and to grow at a CAGR of 9.16% (2026–2035). Plant-extract and natural-compound actives act on nematodes directly, which suits organic growers and export horticulture where residue limits drive input choice. Their registrations often follow low-risk pathways, and the products are less dependent on soil biology than microbial lines. The trade-off is cost per hectare, which keeps most use in vegetables, fruit and nursery stock rather than broadacre crops.

By Mode of Application

Soil treatment

Soil treatment was worth USD 326.4 million in 2025 and is expected to reach USD 809.6 million by 2035. It remains the default because nematodes live in the root zone and preplant, in-furrow and band applications put the product where the pest is. The buyers are fruit, vegetable and row-crop growers who already have soil equipment and a fumigation habit to replace. Spore survival, soil moisture and uniform placement decide results, which is why advisers rather than retailers often steer these purchases.

Seed treatment

Seed treatment held a 22% share in 2025 and is projected to grow at a CAGR of 11.39% (2026–2035). Seed companies and distributors sell a biological pre-applied to soybean, corn and cotton seed, so the grower makes a single purchase and avoids an extra pass. That convenience favors large operations and sits comfortably with planting-time logistics. Shelf life on the seed and compatibility with fungicide and insecticide packages are the technical hurdles that decide which strains win this channel.

Foliar spray

Foliar spray is expected to reach USD 211.2 million by 2035, after holding a 13% share in 2025. It is the narrowest route to the root zone, so products here are mostly used for crops with established canopies, systemic or stimulant-type activity and growers who already spray for other pests. Demand comes from vegetable and fruit growers who want one more application window rather than a replacement for soil treatment, which limits foliar volumes but suits integrated pest management schedules.

Drip/irrigation application

Drip and irrigation application generated USD 74.8 million in 2025 and is expected to grow at a CAGR of 10.94% (2026–2035). Fertigation puts a liquid biological directly into the wetted root zone of tomatoes, strawberries, peppers, orchards and vines, with good control over timing. Buyers are high-value growers with drip infrastructure, and the same installed base lets them repeat treatments through the season. Filter compatibility, product clarity and water quality shape which formulations are accepted.

By Crop Type

Fruits & vegetables

Bionematicides Market Share By Crop Type 2025
Bionematicides Market Share By Crop Type 2025

Fruits and vegetables generated USD 258.4 million in 2025 and are expected to hold a 36% share by 2035. Intensive cropping, continuous planting and high returns per hectare make root-knot damage costly, and export buyers press growers toward lower-residue inputs. Tomatoes, cucurbits, strawberries and citrus are typical users, often through drip lines. This is where biological programs get the most experienced agronomic support, so adoption is less limited by grower knowledge than by registration of specific label claims.

Cereals & grains

Cereals and grains held a 28% share in 2025 and are projected to grow at a CAGR of 10.36% (2026–2035). Corn, wheat and rice growers buy on a per-hectare cost basis and mostly meet biologicals through seed treatment and in-furrow packages from large suppliers. Price pressure is higher than in horticulture, so adoption depends on seed-applied formats and on credible yield-protection results across many fields. Scale in fermentation, not specialty formulation, determines who can serve this crop group.

Oilseeds & pulses

Oilseeds and pulses are projected to reach USD 352 million by 2035, with a CAGR of 11.14% (2026–2035). Soybean dominates, where cyst, root-knot and root-lesion nematodes follow rotations and intensifying production in South America and the U.S. Midwest. Growers buy through seed-treatment programs and in-furrow offers from large input suppliers, and results are measured in bags or bushels per hectare. The crop is also where seed-trait competition will be sharpest later in the forecast.

Commercial crops

Commercial crops generated USD 74.8 million in 2025 and are expected to reach USD 176 million by 2035. Cotton, sugarcane, tobacco and coffee make up this group, and several are long-cycle or perennial crops where nematode pressure builds over seasons and replanting is costly. Plantation managers buy by program, often with agronomist-led trials, and are willing to pay for protection of establishment years. Volume is smaller than in grains, but repeat purchasing is more reliable.

By Formulation

Liquid

Liquid formulations generated USD 387.6 million in 2025 and are expected to hold a 55% share by 2035. Suspension concentrates suit in-furrow application, drip lines and seed-treatment equipment, and fermentation plants naturally produce liquids. Large crop-protection and seed companies prefer them because they integrate with existing sprayers and slurry systems. Cold-chain and shelf-life limits, however, push some suppliers toward dry forms for export and remote markets, which caps liquid's share gains.

Granular/dry granules

Dry granules held a 20% share in 2025 and are projected to grow at a CAGR of 11.03% (2026–2035). Granules carry the biological on a mineral or organic carrier, are applied with planter-box or band equipment and tolerate warehousing better than liquids. Buyers are row-crop and vegetable growers in warm regions, plus distributors who want stable inventory. Higher freight and application cost per hectare are the trade-off, but they pay off where product placement and storage stability matter.

Wettable powder (WDP)

Wettable powders generated USD 95.2 million in 2025 and are expected to reach USD 246.4 million by 2035. Powder formulations of fungal spores and some bacterial products ship light, store well and mix into soil drenches, which suits regional distributors and nurseries. The format has long-standing use in fungal lines such as Purpureocillium lilacinum. Mixing quality and nozzle compatibility are the practical limits, so growth follows trained users in horticulture rather than mechanized broadacre farms.

By Nematode Type

Root-knot nematodes

Root-knot nematodes are expected to account for USD 880 million by 2035, after holding a 52% share in 2025. They attack hundreds of host crops, including tomato, pepper, cucurbits, cotton and soybean, and form galls that block water and nutrient flow. That breadth gives the segment the largest buyer base and explains why most biological nematicide labels list Meloidogyne first. Growers react at the first galls in the field, so demand follows warm, sandy soils and continuous vegetable production.

Cyst nematodes

Cyst nematodes generated USD 149.6 million in 2025 and are expected to grow at a CAGR of 10.47% (2026–2035). Soybean cyst nematode is the main target, and cysts persist in soil for years, so resistant varieties alone lose effect as populations adapt. Buyers are soybean producers in North America and South America who add a seed-applied or in-furrow biological to protect early root growth. Cyst control tends to be a preventive, multi-season spend rather than a reaction to visible damage.

Lesion nematodes

Lesion nematodes held a 14% share in 2025 and are projected to reach USD 264 million by 2035. Pratylenchus species move through roots, cause lesions that open the way for fungal infection and affect soybean, corn, cotton, coffee, potato and fruit trees. Damage is less visible than galling, so detection and soil testing lead purchases. Brazilian soybean and cotton systems are a core market, and new multi-strain products have been registered specifically for lesion control.

GMI Analyst View

Segment demand is shaped less by who makes the product than by where it can be placed and how often the buyer can repeat it. Seed and in-furrow routes will carry the broadacre crops because they add no extra pass, while drip and soil programs will carry higher-value horticulture where agronomic support is stronger. Microbial lines lead on scale, biochemical lines on niche use, and the nematode mix will tilt toward lesion and cyst control as soybean and cotton systems intensify. The risk is a format mismatch, where a good strain meets a poor delivery route.

Bionematicides Market Regional Analysis

Bionematicides Market Share By Region 2025 And 2035
Bionematicides Market Share By Region 2025 And 2035

North America Bionematicides Market Analysis

North America generated USD 156.4 million in 2025 and is expected to account for a 20% share by 2035. Demand comes from two quite different buyers: Midwest corn and soybean growers who add seed-applied biologicals against cyst nematode, and Western specialty-crop growers who face tight fumigation rules. Distribution runs through large retailers, seed companies and crop consultants, which supports branded, program-based products and keeps registration costs a recurring entry barrier.

U.S.

The U.S. generated USD 136.07 million in 2025 and accounted for an 87% share of the regional total that year. California, Florida and the Pacific Northwest drive horticulture and orchard demand, while the Corn Belt drives seed-treatment volume. Federal registration and state-level fumigant rules shape what can be sold, and custom applicators and crop consultants influence purchases. This mix of high-value and broadacre buyers is wider than in most other single countries.

Canada

Canada is expected to reach USD 45.76 million by 2035 and to grow at a CAGR of 8.45% (2026–2035). Prairie soybean and pulse acreage, plus Ontario and Quebec vegetable and potato production, create pockets of demand. Short growing seasons, cold soils and a smaller retail network make adoption steadier than fast. Products registered in the United States often reach Canadian growers through the same distributors, but separate federal registration keeps the product range narrower.

Europe Bionematicides Market Analysis

Europe held a 20% share in 2025 and is projected to reach USD 334.4 million by 2035. Regulation is the main driver: the Union has withdrawn several soil-applied chemistries and applies strict residue limits, so protected vegetable, potato and fruit growers look to biologicals that qualify as low-risk. Retailer residue requirements add pressure. Slow, country-by-country product authorizations are the constraint, and zonal procedures only partly offset it.

Germany

Germany generated USD 34 million in 2025 and is expected to grow at a CAGR of 10.00% (2026–2035). Potato, sugar beet, vegetables and hops are the crops where nematode management matters, and growers work closely with advisory services and cooperatives. Integrated pest management rules and retail residue demands favor biological programs. Germany is where new labels and consortia are often tested first, and compliance expectations are high.

UK

The UK held a 19% share of regional demand in 2025 and is expected to reach USD 63.54 million by 2035. Potato, field vegetables and soft fruit dominate, and potato cyst nematode is the central concern, since land is contaminated for years and rotations are tight. Supermarket-driven residue protocols push growers toward biologicals as chemical options narrow. The UK's separate post-Brexit regulator also decides which biological products reach growers, creating a distinct approval track.

France

France held an 18% share of the regional market in 2025 and is expected to grow at a CAGR of 9.41% (2026–2035). Vegetables, vineyards, fruit and sugar beet make up the main use cases, and growers have historically had fewer chemical nematicide options than in southern neighbors. Cooperative advisers and biocontrol policy support push farmers toward registered biological solutions. The pace is set by the national authorization process and by the willingness of cooperatives to run field demonstrations.

Italy

Italy generated USD 20.4 million in 2025 and is projected to reach USD 50.16 million by 2035. Protected tomato, melon, pepper and strawberry production in the south, along with orchards, makes root-knot nematodes a long-standing problem. After the loss of soil fumigants and fluopyram restrictions, growers have tested biological and physical alternatives. Small farm sizes and dependence on regional distributors mean adoption spreads through local trials and technician networks.

Asia Pacific Bionematicides Market Analysis

Asia Pacific is projected to reach USD 528 million by 2035, growing at a CAGR of 12.00% (2026–2035), the fastest of the five regions. Vegetables, rice, fruit, tea and cotton are grown by many small farms, and governments are promoting biological inputs and organic area. Distribution through agri-input dealers and farmer cooperatives, together with new product registrations in India, Vietnam and Indonesia, widens access. Variation in registration rules and in grower knowledge is the main brake.

China

China generated USD 59.5 million in 2025 and is expected to reach USD 184.8 million by 2035. The country combines intensive greenhouse vegetable production, where root-knot is severe, with policy aimed at reducing chemical pesticide use. Domestic fermenters supply many microbial products at low prices, and extension systems promote biological control in vegetables and fruit. Registration of new microbial actives is selective, so established local strains dominate.

Japan

Japan held a 20% share of regional revenue in 2025 and is projected to reach USD 73.4 million by 2035. Growers of vegetables, sweet potato, tea and fruit are precise about timing and input quality, and agricultural cooperatives influence purchasing. Low-risk and organic-compatible products suit the country's push to reduce chemical use. Small plot sizes and an aging farm population limit volume growth, so value comes from premium formulations rather than acreage.

South Korea

South Korea is expected to account for a 7.98% share of the regional market by 2035 and to grow at a CAGR of 9.50% (2026–2035). Greenhouse vegetables such as melon, strawberry, pepper and cucumber, grown continuously in the same houses, create persistent root-knot pressure. Government support for eco-friendly farming and a tightly managed registration process steer growers toward certified biologicals. The country is a small, high-spending market where product quality and local trial data matter.

India

India generated USD 34 million in 2025 and is expected to grow at a CAGR of 14.53% (2026–2035), the fastest among the named countries. Vegetables, banana, sugarcane, cotton and pulses suffer substantial nematode damage, and state programs promote biological inputs and natural farming. Domestic fermenters, including firms that serve cooperatives, supply low-cost microbial and neem-based products through agri-input dealers. Quality control, shelf life and uneven registration enforcement remain the issues that separate branded suppliers from informal ones.

Latin America Bionematicides Market Analysis

Latin America held a 26% share in 2025, the largest of any region, and is expected to grow at a CAGR of 9.55% (2026–2035). Large-scale soybean, corn, cotton, sugarcane and coffee systems face persistent nematode pressure, and growers are used to purchasing biological inputs. Brazilian regulation has encouraged both multinational and local suppliers, and on-farm production by large operations is also a competitive factor.

Brazil

Brazil is projected to reach USD 312.4 million by 2035, after holding a 70% share of Latin American revenue in 2025. Soybean, cotton, corn and sugarcane producers buy bionematicides in furrow and on seed, and local companies compete with multinationals through Brazilian-isolated strains. The bioinputs law and ministry registration have increased label activity. Cerrado expansion and double-cropping keep nematode populations building, which sustains demand season after season.

Mexico

Mexico is expected to reach USD 74.8 million by 2035 and to grow at a CAGR of 8.92% (2026–2035). Export vegetables, berries, avocado, citrus and sugarcane dominate demand, and buyers must meet residue requirements set by U.S. and European retailers. Protected horticulture in Sinaloa, Jalisco and Michoacán adopts drip-applied biologicals earliest. Distribution via regional dealers and technical representatives tied to export growers makes adoption quicker among large producers than smallholders.

Middle East & Africa Bionematicides Market Analysis

The Middle East and Africa generated USD 40.8 million in 2025 and are projected to reach USD 105.6 million by 2035. Irrigated horticulture, date palms, cereals under center-pivot irrigation and export fruit are the primary users, and food-security programs support input modernization. Demand is concentrated in a few countries, and distribution through import agents and large estates makes procurement lumpy. Registration capacity and climate stress on microbial survival are the principal constraints.

South Africa

South Africa generated USD 10.2 million in 2025 and is expected to grow at a CAGR of 9.53% (2026–2035). Citrus, grapes, deciduous fruit, sugarcane and vegetables, much of it exported, require compliance with retailer residue limits. Commercial estates employ crop consultants and test biological products against nematode problems in orchards and vineyards. A developed distribution network and local fermentation capability make it the continent's most mature market for these inputs.

Saudi Arabia

Saudi Arabia held a 22% share of regional revenue in 2025 and is expected to reach USD 23.23 million by 2035. Greenhouse vegetables, date palms and irrigated forage production create steady nematode pressure in sandy soils. Government programs promote domestic food production and lower chemical residues, and large agricultural companies are the main buyers. Product choice is influenced by heat tolerance, since high soil temperatures can reduce microbial survival, so formulations suited to drip systems have an advantage.

UAE

The UAE generated USD 6.12 million in 2025 and is projected to reach USD 14.78 million by 2035. Demand is small and tied to protected agriculture, vertical and greenhouse farms and landscaping, where growers use soilless or sandy media and favor residue-free inputs. Imported products pass through a handful of agri-input distributors, and buyers value technical support. The UAE's focus on local food production gives biological inputs more attention than its acreage suggests.

GMI Analyst View

Regional outcomes depend on the interaction of crop mix, regulation and distribution. Latin America and Asia Pacific will drive volume because large crop areas and active registration programs meet rising nematode pressure, while Europe and North America will be shaped by restrictions on chemistry and by authorization speed. Middle East and Africa will advance in pockets where irrigated horticulture and export standards create buyers. Country markets that combine export crops with strong advisory networks tend to adopt faster than those relying on smallholders and informal supply.

Bionematicides Market Share & Competitive Landscape

The market is moderately concentrated: the top five suppliers hold a combined bionematicides market share of 46% in 2025, while the remainder is spread among crop-protection majors, regional fermenters and specialist biological companies. Competition turns on strain performance, formulation stability, access to seed-treatment and retail channels, registration breadth and technical support in the field. The field divides into biorational specialists with their own fermentation, global crop-protection groups adding biologicals through acquisition or partnership, and regional producers serving local crops.

Sumitomo Biorational Company LLC (formerly Valent BioSciences LLC)

Sumitomo Biorational Company LLC (formerly Valent BioSciences LLC) leads the market with a 13% share in 2025. The Libertyville, Illinois company brings together Sumitomo Biorational, MGK and Valent North America as Sumitomo Chemical's global center of excellence for biorational innovation, covering microbial and botanical products. Its position rests on in-house fermentation, a long-established biorational portfolio and access to its parent's global sales network.

Koppert Biological Systems

Koppert Biological Systems holds an 11% share. The Dutch company is the best-known independent biological-control specialist, selling microbial and macrobial solutions directly to growers through its own technical teams. In Brazil it runs a microbial plant at Charqueada that produces bacteria-, fungi- and virus-based inputs and has moved into seed treatment, which supports its position in soybean and cotton. Direct advisory selling is its edge.

BASF SE

BASF SE holds a 9% share. Its biological nematode offer centers on Poncho Votivo Precise, a seed treatment that pairs an insecticide with Bacillus firmus strain I-1582 for nematode protection, and it is developing the Nemasphere soybean trait for later launch. That combination gives BASF a seed-treatment channel and a trait pipeline, tying nematode control to its seed and crop-protection customers.

Certis Biologicals

Certis Biologicals, a subsidiary of Mitsui & Co., sells biological pest-control products across row crops, specialty crops and turf. Its NemaClean, based on Purpureocillium lilacinum strain PL11, is a wettable powder authorized in the Netherlands for root-knot nematodes in fruiting vegetables, and Certis-Belchim is taking it through further European assessments. Solid and liquid fermentation capacity and a European partnership give it reach in protected vegetables.

Other crop-protection majors in the competitive set include Bayer AG, Corteva Agriscience, FMC Corporation, UPL Limited, Syngenta AG, Nufarm Limited, ADAMA Ltd. and Sumitomo Chemical Co., Ltd. Corteva has introduced Amaná, a three-strain microbial nematicide for Brazil, and UPL sells the Numaxa bio-nematicide seed treatment for corn and soybean in North America. These groups compete through seed treatments, in-furrow packages and distribution rather than stand-alone biological franchises.

Specialist and regional biological suppliers include Andermatt Biocontrol AG, Lallemand Inc., T. Stanes & Company Limited, Pro Farm Group (Bioceres Crop Solutions), Indigo Ag, Inc. and Novonesis. They bring microbial strains, fermentation and enzyme capability, and regional distribution in Europe, India, the Americas and global industrial biology, and several are likely partners or acquisition targets for larger companies seeking nematode-control assets.

Recent Industry Developments

November 2026: Corteva Agriscience began selling Amaná, a microbial nematicide for root-lesion nematode, after Brazilian regulatory approval. It combines Bacillus licheniformis, Bacillus velezensis and Priestia megaterium strains and is applied in the planting furrow [5].

November 2026: BASF announced the Nemasphere brand for a soybean seed biotechnology against root-lesion and cyst nematodes, targeting Brazil and the United States, with commercial seed to follow regulatory approvals [6].

Need a specific section of this report?

Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.


Authors:  Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQs):

The bionematicides market size was estimated at USD 680 million in 2025 and is expected to reach USD 748 million in 2026.
The market is projected to reach USD 1.76 billion by 2035, growing at a CAGR of 9.97% from 2026 to 2035.
Latin America currently holds the largest share of the bionematicides market in 2025.
Asia Pacific is projected to be the fastest-growing region during the forecast period.
Some of the major players in bionematicides market include Sumitomo Biorational Company LLC (formerly Valent BioSciences LLC), Koppert Biological Systems, BASF SE, Certis Biologicals, Bayer AG.

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 20+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Industry journals, trade publications, and specialized media.

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 20+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Authors:  Kiran Pulidindi, Kunal Ahuja
We use cookies to enhance user experience. (Privacy Policy)